Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands
Cancer Epidemiology · 2023-08 · 85 · 102405
DOI: 10.1016/j.canep.2023.102405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Epidemiology, 2023-08. Verfasst von Eline J Oymans und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands; D…. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: To study the impact of the COVID-19 pandemic and consequent lockdown on the number of diagnoses of gynaecological malignancies in the Netherlands. METHODS: We performed a retrospective cohort study using data from the Netherlands Cancer Registry (NCR) on women of 18 years and older diagnosed with invasive endometrial, ovarian, cervical or vulvar cancer in the period 2017-2021. Analyses were stratified for age, socioeconomical status (SES) and region. RESULTS: The incidence rate of gynaecological cancer was 67/100.000 (n = 4832) before (2017-2019) and 68/100.000 (n = 4833) during (2020) the COVID-19 pandemic. Comparing the number of diagnoses of the two periods for the four types of cancer separately showed no significant difference. During the first wave of COVID-19 (March-June 2020), a clear decrease in number of gynaecological cancer diagnoses was visible (20-34 %). Subsequently, large increases in number of diagnoses were visible (11-29 %). No significant differences in incidence were found between different age groups, SES and regions. In 2021 an increase of 5.9 % in number of diagnoses was seen. CONCLUSION: In the Netherlands, a clear drop in number of diagnoses was visible for all four types of gynaecological cancers during the first wave, with a subsequent increase in number of diagnoses in the second part of 2020 and in 2021. No differences between SES groups were found. This illustrates good organisation of and access to health care in the Netherlands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands; Department of Obstetrics and Gynecology, University Medical Center Gron…
- Department of Obstetrics and Gynecology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
- University of Groningen, University Medical Center Groningen, Department of Pathology, Hanzeplein 1, 9713 GZ Groningen, the Netherlands.
- Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands.
- Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands.
Zitieren
APA
Oymans, E. J., de Kroon, C. D., Bart, J., Nijman, H. W., & van der Aa, M. A. (2023). Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands. Cancer Epidemiology, 85, 102405. https://doi.org/10.1016/j.canep.2023.102405
Vancouver
Oymans EJ, de Kroon CD, Bart J, Nijman HW, van der Aa MA. Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands. Cancer Epidemiology. 2023;85:102405. doi:10.1016/j.canep.2023.102405
BibTeX
@article{Oymans2023,
author = {Oymans, Eline J and de Kroon, Cor D and Bart, Joost and Nijman, Hans W and van der Aa, Maaike A},
title = {Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands},
journal = {Cancer Epidemiology},
year = {2023},
volume = {85},
pages = {102405},
doi = {10.1016/j.canep.2023.102405}
}
EUVIMED